The information in the ovarian cancer information centre is based on the Cancerbackup booklet, Understanding cancer of the ovary, which was produced in accordance with the following sources and guidelines:

• Chemotherapy for advanced ovarian cancer.  Advanced ovarian cancer triallists group. The Cochrane Database Of Systematic Reviews 2006. Issue 1.
• Oxford Textbook of Palliative Medicine. (2nd Edition) Derek Doyle et al. Oxford University Press. 1999.
• Improving Supportive and Palliative Care for Adults with Cancer – The Manual. National Institute for Clinical Excellence (NICE). March 2004.
• Review Of The Clinical Effectiveness And Cost Effectiveness Of Paclitaxel For Ovarian Cancer. National Institute for Clinical Excellence. January 2003.
• Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer (review). Assessment report. National Institute for Clinical Excellence. December 2004.
• Guidance on the use of pegylated liposomal doxorubicin hydrochloride (Caelyx) for advanced ovarian cancer. National Institute for Clinical Excellence. 2002.
• Improving Outcomes In Gynaecological Cancers: Guidance On Commissioning Cancer Services. Department of Health. London 1999.
• Scottish Referral Guidelines for Suspected Cancer. Scottish Executive, 2002.

Guidelines are constantly being updated and those noted above may have been revised since the booklet was produced. You can access up-to-date guidelines in the health professionals section of the website.